Cargando…
A Comorbidity Model of Myocardial Ischemia/Reperfusion Injury and Hypercholesterolemia in Rat Cardiac Myocyte Cultures
INTRODUCTION: The use of comorbidity models is crucial in cardioprotective drug development. Hypercholesterolemia causes endothelial and myocardial dysfunction, as well as aggravates ischemia/reperfusion (I/R)-induced myocardial injury. Endogenous cardioprotective mechanisms against I/R are impaired...
Autores principales: | Makkos, András, Szántai, Ágnes, Pálóczi, János, Pipis, Judit, Kiss, Bernadett, Poggi, Paola, Ferdinandy, Péter, Chatgilialoglu, Alexandros, Görbe, Anikó |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962358/ https://www.ncbi.nlm.nih.gov/pubmed/31992989 http://dx.doi.org/10.3389/fphys.2019.01564 |
Ejemplares similares
-
Decorin Protects Cardiac Myocytes against Simulated Ischemia/Reperfusion Injury
por: Gáspár, Renáta, et al.
Publicado: (2020) -
Rosiglitazone Does Not Show Major Hidden Cardiotoxicity in Models of Ischemia/Reperfusion but Abolishes Ischemic Preconditioning-Induced Antiarrhythmic Effects in Rats In Vivo
por: Weber, Bennet Y., et al.
Publicado: (2022) -
Lack of Contribution of p66shc and Its Mitochondrial Translocation to Ischemia-Reperfusion Injury and Cardioprotection by Ischemic Preconditioning
por: Boengler, Kerstin, et al.
Publicado: (2017) -
Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion
por: Brenner, Gábor B., et al.
Publicado: (2020) -
Exogenous Nitric Oxide Protects Human Embryonic Stem Cell-Derived Cardiomyocytes against Ischemia/Reperfusion Injury
por: Pálóczi, János, et al.
Publicado: (2016)